Ascenta Capital was born to help innovative companies as they grow from their scientific foundations to advance the clinical development of meaningful medicines for patients. We make concentrated investments and work in collaboration to support our management teams with our strategic and operational experience.

01.

Deep Scientific Insight

We make concentrated investments and work in collaboration to support our manag

02.

Patient-Centered Approach

We invest in innovations that have the power to make a meaningful difference in patients’ lives, keeping patient needs at the heart of every decision.

03.

Strategic Growth Support

Beyond capital, we provide strategic guidance, connections, and resources to help our partners scale effectively and sustainably.

Our Strategy

Phase 1 and 2

We partner with companies that have development candidates, translating their preclinical science into early human safety and efficiency data.

Platforms

We believe there lies opportunity in multi-medicine platforms. Complex questions of growth, strategy and value creation are front and center, and offer asymmetric upside

Our Values

Originate Conviction

Act Decisively

Be Collaborative

Stay Nimble

Patients are waiting. Biopharma’s essence is delivering innovative medicines to patients with major unmet needs. Management, scientists, clinical investigators, and investors all together strive towards that shared goal. Today, the biotech renaissance is in full swing.

This is the time to invest.

The global convergence of biological and chemical insights, life science technology, data analytics, talent, and capital is unprecedented.

The global convergence of biological and chemical insights, life science technology, data analytics, talent and capital is unprecedented.

info@ascentacap.com

Translating Science into Medicines

$335 Million

Assets Under Management

$15-30 Million

Biotech Investments

01.